VOL. XCIV, NO. 247

★ FINANCIAL TOOLS & SERVICES DIRECTORY ★

PRICE: 5 CENTS

Sunday, October 5, 2025

Head-to-head

CME FedWatch Tool vs Portfolio123 comparison

Compare pricing, supported platforms, categories, and standout capabilities to decide which tool fits your workflow.

Quick takeaways

CME FedWatch Tool adds Central Bank Watcher, and Interest Rates coverage that Portfolio123 skips.

Portfolio123 includes Screeners, Quant, Backtesting, Portfolio, Correlation, and Broker Connectors categories that CME FedWatch Tool omits.

CME FedWatch Tool highlights: Meeting‑by‑meeting probabilities of FOMC target‑rate outcomes implied by Fed Funds futures., Compare view (current vs 1‑day/1‑week/1‑month ago) and Historical panel., and Fed ‘Dot Plot’ chart plus table view..

Portfolio123 is known for: Build custom multi-factor ranking systems and rank stocks by universe, sector, or industry., Spreadsheet-style screening with formulas (including Piotroski F-Score) across current and historical data., and Backtesting with realistic assumptions for slippage, commissions, buy/sell rules, position sizing, and hedging..

CME FedWatch Tool logo

CME FedWatch Tool

cmegroup.com

Official CME probabilities for upcoming FOMC decisions, derived from 30‑Day Fed Funds (ZQ) futures. Web tool provides meeting‑by‑meeting probability matrices, comparisons over time, a historical download, and a Dot Plot view. A paid REST API is available for programmatic access. CME documents the probability‑tree methodology clearly; API snapshots update on business days at ~01:45 UTC. Media usage asks attribution to “CME FedWatch.”

Platforms

Web
API

Pricing

Free
Subscription

Quick highlights

  • Meeting‑by‑meeting probabilities of FOMC target‑rate outcomes implied by Fed Funds futures.
  • Compare view (current vs 1‑day/1‑week/1‑month ago) and Historical panel.
  • Fed ‘Dot Plot’ chart plus table view.
  • One‑click PDF generation of the current page and Excel downloads for historical probabilities.
  • Transparent methodology: unconditional probabilities via a binary probability tree built from implied EFFR, assuming 25 bp step sizes.

Community votes (overall)

0% upvotes 0% downvotes
You haven't voted yet
Portfolio123 logo

Portfolio123

portfolio123.com

Editor’s pick Hands-on review

Quant research and live-deployment platform with point-in-time fundamentals and estimates. Users can screen, backtest, and simulate strategies, then deploy them live with broker integrations. Supports API access and a no-code desktop DataMiner. FactSet or S&P Compustat licenses are required for full historical fundamentals.

Platforms

Web
Desktop
API

Pricing

Free
Subscription

Quick highlights

  • Build custom multi-factor ranking systems and rank stocks by universe, sector, or industry.
  • Spreadsheet-style screening with formulas (including Piotroski F-Score) across current and historical data.
  • Backtesting with realistic assumptions for slippage, commissions, buy/sell rules, position sizing, and hedging.
  • ‘Books’ feature to combine multiple strategies and view correlations between them.
  • Point-in-time fundamentals, estimates, and corporate actions with dividends handled on ex/pay dates (no survivorship bias or look-ahead).

Community votes (overall)

0% upvotes 0% downvotes
You haven't voted yet
Overlap

Shared focus areas

4 overlaps

Mutual strengths include Data APIs, APIs & SDKs, and Data Visualizations plus 1 more area.

Where they differ

CME FedWatch Tool

Distinct strengths include:

  • Meeting‑by‑meeting probabilities of FOMC target‑rate outcomes implied by Fed Funds futures.
  • Compare view (current vs 1‑day/1‑week/1‑month ago) and Historical panel.
  • Fed ‘Dot Plot’ chart plus table view.
  • One‑click PDF generation of the current page and Excel downloads for historical probabilities.

Portfolio123

Distinct strengths include:

  • Build custom multi-factor ranking systems and rank stocks by universe, sector, or industry.
  • Spreadsheet-style screening with formulas (including Piotroski F-Score) across current and historical data.
  • Backtesting with realistic assumptions for slippage, commissions, buy/sell rules, position sizing, and hedging.
  • ‘Books’ feature to combine multiple strategies and view correlations between them.

Feature-by-feature breakdown

AttributeCME FedWatch ToolPortfolio123
Categories

Which research workflows each platform targets

Shared: Data APIs, APIs & SDKs, Data Visualizations, Calendar

Unique: Central Bank Watcher, Interest Rates

Shared: Data APIs, APIs & SDKs, Data Visualizations, Calendar

Unique: Screeners, Quant, Backtesting, Portfolio, Correlation, Broker Connectors

Asset types

Supported asset classes and universes

Futures

Stocks, ETFs

Experience levels

Who each product is built for

Beginner, Intermediate, Advanced

Beginner, Intermediate, Advanced

Platforms

Where you can access the product

Web, API

Web, Desktop, API

Pricing

High-level pricing models

Free, Subscription

Free, Subscription

Key features

Core capabilities called out by each vendor

Unique

  • Meeting‑by‑meeting probabilities of FOMC target‑rate outcomes implied by Fed Funds futures.
  • Compare view (current vs 1‑day/1‑week/1‑month ago) and Historical panel.
  • Fed ‘Dot Plot’ chart plus table view.
  • One‑click PDF generation of the current page and Excel downloads for historical probabilities.
  • Transparent methodology: unconditional probabilities via a binary probability tree built from implied EFFR, assuming 25 bp step sizes.
  • FedWatch REST API (OAuth2) with endpoints for /forecasts and /meetings (future/history); extended history available.

Unique

  • Build custom multi-factor ranking systems and rank stocks by universe, sector, or industry.
  • Spreadsheet-style screening with formulas (including Piotroski F-Score) across current and historical data.
  • Backtesting with realistic assumptions for slippage, commissions, buy/sell rules, position sizing, and hedging.
  • ‘Books’ feature to combine multiple strategies and view correlations between them.
  • Point-in-time fundamentals, estimates, and corporate actions with dividends handled on ex/pay dates (no survivorship bias or look-ahead).
  • Coverage of 15,000+ equities in the U.S., Canada, and Europe, including delisted stocks and spinoffs.
Tested

Verified by hands-on testing inside Find My Moat

Not yet

Yes

Editor pick

Featured inside curated shortlists

Standard listing

Highlighted

Frequently Asked Questions

Which workflows do CME FedWatch Tool and Portfolio123 both support?

Both platforms cover Data APIs, APIs & SDKs, Data Visualizations, and Calendar workflows, so you can research those use cases in either tool before digging into the feature differences below.

Do CME FedWatch Tool and Portfolio123 require subscriptions?

Both CME FedWatch Tool and Portfolio123 keep freemium access with optional paid upgrades, so you can trial each platform before committing.

How can you access CME FedWatch Tool and Portfolio123?

Both CME FedWatch Tool and Portfolio123 prioritize web or desktop access. Investors wanting a mobile-first workflow may need to rely on responsive web views.

What unique strengths set the two platforms apart?

CME FedWatch Tool differentiates itself with Meeting‑by‑meeting probabilities of FOMC target‑rate outcomes implied by Fed Funds futures., Compare view (current vs 1‑day/1‑week/1‑month ago) and Historical panel., and Fed ‘Dot Plot’ chart plus table view., whereas Portfolio123 stands out for Build custom multi-factor ranking systems and rank stocks by universe, sector, or industry., Spreadsheet-style screening with formulas (including Piotroski F-Score) across current and historical data., and Backtesting with realistic assumptions for slippage, commissions, buy/sell rules, position sizing, and hedging..

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.